HEALTH OPTIMIZER
CVS Pharmacy, Inc.
Application Filed: 2021-12-02
Trademark Application Details
STATEMENT OF USE - TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97976993 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Erich G. Rhynhart |
| Law Office Assigned | L90 |
| Employee Name | LIU, PHILIP HUAI-EN |
Timeline
| 2021-12-02 | Application Filed |
| 2022-01-01 | Date of First Use |
| 2023-04-04 | Published for Opposition |
| 2023-11-28 | Location: TMEG LAW OFFICE 109 |
| 2023-11-28 | Status: Live/Pending |
| 2023-11-28 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CVS Pharmacy, Inc. |
| Address | Mailcode: 1160 One CVS Drive Woonsocket RI 02895 |
| Legal Entity Type | Corporation |
| Legal Entity State | RI |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| Type Code | Type |
|---|---|
| GS0091 | Downloadable mobile application for use in the acquisition, storage, organizing, tracking, sharing, and analysis of medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; Downloadable mobile application for providing coaching and education in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; Downloadable mobile application for preparing and delivering reports and analytics relating to medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; Downloadable mobile application for delivery of medical and physiological data and clinical decision support to healthcare organizations, healthcare providers, and healthcare professionals |
| GS0091 | Downloadable mobile application for use in the acquisition, storage, organizing, tracking, sharing, and analysis of medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; Downloadable mobile application for providing coaching and education in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; Downloadable mobile application for preparing and delivering reports and analytics relating to medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; Downloadable mobile application for delivery of medical and physiological data and clinical decision support to healthcare organizations, healthcare providers, and healthcare professionals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2021-12-06 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-12-06 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2022-08-18 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-08-31 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2022-08-31 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-08-31 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-02-03 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-02-03 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-02-03 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-02-27 | 10 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-03-15 | 11 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2023-04-04 | 12 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-04-04 | 13 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-05-30 | 14 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2023-11-15 | 15 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-11-28 | 16 AITU A:Allowance for Publication |
| TEAS REQUEST TO DIVIDE RECEIVED | 2023-11-15 | 17 ERTD I:Incoming Correspondence |
| DIVISIONAL REQUEST RECEIVED | 2023-11-15 | 18 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2023-11-28 | 19 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2023-11-15 | 20 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2023-11-28 | 21 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2023-11-29 | 22 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2023-11-30 | 23 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-01-02 | 24 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-01-02 | 25 NRCC E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HEALTH OPTIMIZER 97976993 not registered Live/Pending |
CVS Pharmacy, Inc. 2021-12-02 |
 HEALTH OPTIMIZER 97152314 not registered Live/Pending |
CVS Pharmacy, Inc. 2021-12-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 